🧪
hypothesis

GluN2B-Mediated Microglial Activation and Tau Phagocytosis

Hypothesis

GluN2B-Mediated Microglial Activation and Tau Phagocytosis

This hypothesis proposes that GluN2B-containing NMDA receptors on microglia directly regulate tau protein clearance through enhanced phagocytic activity rather than glymphatic drainage.
🧬 GRIN2B🩺 neuroscience🎯 Composite 38%proposed
EvidencePending (0%)📖 19 cit🗣 3 debates 16 support 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.75 (15%) Evidence 0.59 (15%) Novelty 0.00 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.95 (10%) Safety 0.75 (8%) Competition 0.80 (6%) Data Avail. 0.70 (5%) Reproducible 0.75 (5%) KG Connect 0.56 (8%) 0.380 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite38%

🧪 Overview

This hypothesis proposes that GluN2B-containing NMDA receptors on microglia directly regulate tau protein clearance through enhanced phagocytic activity rather than glymphatic drainage. GluN2B subunits (encoded by GRIN2B) are expressed on microglial processes that extend into synaptic clefts and perineuronal spaces, where they respond to pathological glutamate release from tau-burdened neurons. Upon activation, these receptors generate sustained calcium influx that triggers a specific microglial phenotypic switch characterized by upregulation of phagocytic receptors including TREM2, CD68, and complement receptor 3. The calcium-dependent activation of calcineurin dephosphorylates nuclear factor of activated T-cells (NFAT), promoting its nuclear translocation and transcriptional upregulation of genes encoding lysosomal enzymes such as cathepsin D and hexosaminidase A. Simultaneously, GluN2B-mediated calcium signaling activates the mTOR pathway through calcium/calmodulin-dependent protein kinase kinase β (CaMKKβ), enhancing autophagosome formation and fusion with lysosomes. This creates an enhanced degradative capacity specifically targeted toward hyperphosphorylated tau species.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

graph TD
    A["GluN2B NMDA Receptor<br/>Extrasynaptic Expression"] --> B["Calcium Influx<br/>Ca2+ Permeable Channel"]
    B --> C["CaMKII Activation<br/>Calcium-Dependent Kinase"]
    C --> D["CREB Phosphorylation<br/>Transcription Factor"]
    D --> E["Synaptic Plasticity Genes<br/>LTP Enhancement"]
    
    A --> F["Thalamic Relay Neurons<br/>VB and VPM Nuclei"]
    F --> G["Cortical Layer IV<br/>Sensory Input Processing"]
    G --> H["Pyramidal Neurons<br/>Layer V Output"]
    
    A --> I["Gamma Oscillations<br/>40-100 Hz Frequency"]
    I --> J["Theta Oscillations<br/>4-8 Hz Frequency"]
    J --> K["Thalamocortical Synchrony<br/>Network Coordination"]
    
    L["GluN2B Positive Modulator<br/>Therapeutic Intervention"] --> A
    L --> M["Enhanced NMDA Function<br/>Prolonged Deactivation"]
    M --> N["Sustained Depolarization<br/>Temporal Integration"]
    N --> K
    
    O["Neurodegeneration<br/>Pathological State"] --> P["Reduced GluN2B Expression<br/>Receptor Downregulation"]
    P --> Q["Disrupted Oscillations<br/>Loss of Synchrony"]
    Q --> R["Cognitive Impairment<br/>Functional Outcome"]

classDef normal fill:#4fc3f7,color:#0d0d1a
classDef therapeutic fill:#81c784,color:#0d0d1a
classDef pathology fill:#ef5350,color:#0d0d1a
classDef outcome fill:#ffd54f,color:#0d0d1a
classDef molecular fill:#ce93d8,color:#0d0d1a

class A,B,C,D,E,M,N normal
class L therapeutic
class O,P,Q pathology
class R outcome
class F,G,H,I,J,K molecular

⚖️ Evidence

⚖️ Evidence Matrix16 supports3 contradicts
Supports
Thalamocortical circuit integrity differentiates normal aging from mild cognitive impairment, with decreased neural complexity and increased synchronization being hallmarks of dysfunction
PMID:19449329
Supports
NMDA receptor function is required for Aβ-induced synaptic depression, indicating these receptors are key mediators of circuit dysfunction
PMID:23431156
Supports
GluN2B subunits play distinct roles in visual cortical plasticity
PMID:26282667
Supports
Inhibition of GluN2B-containing N-methyl-D-aspartate receptors by radiprodil.
Brain2026PMID:40994429
Supports
Cognitive loss after brain trauma results from sex-specific activation of synaptic pruning processes.
Brain2026PMID:40796363
Supports
Aberrant mRNA splicing and impaired hippocampal neurogenesis in Grin2b mutant mice.
iScience2026PMID:41675057
Supports
From synapse to system: mechanistic pathways of neural signaling dysfunction in psychiatric disorders.
Front Cell Dev Biol2026PMID:41799440
Supports
GluN2B-specific NMDAR positive allosteric modulation reverses cognitive and behavioral abnormalities in Mecp2 and Disc1 transgenic mice.
Sci Adv2026PMID:41512078
Supports
Multi-biofluid metabolomics coupled with gene network reveals stage-specific alterations in mild cognitive impairment and Alzheimer's disease in an ethnically mixed cohort.
Brain Res2026PMID:41534821
Supports
Multisession epidural direct current stimulation of the auditory cortex mitigates age-related transcriptomic dysregulation in Wistar rats.
Hear Res2026PMID:41747412
Supports
Zipper-interacting Protein Kinase Modulates Gene Expression Linked to Synaptic and Neuronal Processes after Traumatic Brain Injury.
Mol Neurobiol2026PMID:41526727
Supports
Inspired by molecular dynamic simulation, exploring chemical constituents of alcoholic extract of Garuga pinnata computationally as inhibitors of GluN2B-containing NMDA receptors.
J Biomol Struct Dyn2026PMID:40166865
Supports
Cellular Prion Protein Engages the N-Methyl-d-Aspartate Receptor through N- and C-Terminal Domains.
Biochemistry2026PMID:41860118
Supports
Molecular mechanism of ligand gating and opening of NMDA receptor.
Nature2024PMID:39085540
Supports
Mechanism of conductance control and neurosteroid binding in NMDA receptors.
Nature2025PMID:41162707
Supports
Synaptic rearrangement of NMDA receptors controls memory engram formation and malleability in the cortex.
Sci Adv2024PMID:39213354
Contradicts
NMDA receptors mediate synaptic depression in amyloid models, suggesting NMDA enhancement could worsen dysfunction rather than improve it
PMID:30352630
Contradicts
Epigenetics in Learning and Memory.
Subcell Biochem2025PMID:39820860
Contradicts
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry.
Neuropsychopharmacology2024PMID:37369776
📖 Linked Papers (4)Export BibTeX ↗
Differential vulnerability of hippocampal CA3-CA1 synapses to Aβ.
Acta Neuropathol Commun (2022) · PubMed:35379353 ↗
No figures
Tau accumulation triggers STAT1-dependent memory deficits by suppressing NMDA receptor expression.
EMBO Rep (2019) · PubMed:31085626 ↗
No figures
Chronic brain inflammation causes a reduction in GluN2A and GluN2B subunits of NMDA receptors and an increase in the phosphorylation of mitogen-activated protein kinases in the hippocampus.
Mol Brain (2014) · PubMed:24761931 ↗
No figures
Activation of NR1a/NR2B receptors by soluble factors from APP-stimulated monocyte-derived macrophages: implications for the pathogenesis of Alzheimer's disease.
Neurobiol Aging (2004) · PubMed:15212844 ↗
No figures

🏥 Translation

🧬 3D Protein Structure — GRIN2B

🧬 PDB 7EU8 Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for GRIN2B from GTEx v10.

Frontal Cortex BA96.5 Nucleus accumbens basal ganglia5.8 Cortex5.1 Anterior cingulate cortex BA243.9 Caudate basal ganglia3.7 Hippocampus2.6 Putamen basal ganglia2.4 Amygdala2.1 Hypothalamus1.6 Cerebellum0.6 Cerebellar Hemisphere0.5 Substantia nigra0.4 Spinal cord cervical c-10.2median TPM (GTEx v10)

💉 Clinical Trials (8)Relevance: 45%

0
Active
0
Completed
1,633
Total Enrolled
PHASE1
Highest Phase
The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain FunctionPHASE1
COMPLETED·NCT00526968 · Evotec Neurosciences GmbH
19 enrolled · 2007-09 · → 2007-12
The purpose of this study is to investigate the neurophysiological changes following single doses of EVT 101 using fMRI during rest and during cognitive tasks in young healthy male subjects.
Human Volunteers
EVT 101 EVT 101 placebo
The Dortmund Vital Study: Impact of Biological and Lifestyle Factors on Cognitive Performace and Work AbilityN/A
ACTIVE_NOT_RECRUITING·NCT05155397 · Technical University of Dortmund
627 enrolled · 2016-04 · → 2035-12
The goal of the Dortmund Vital Study is to validate previous hypotheses and to generate and validate new hypotheses about the relationship of ageing, working conditions, genetic makeup, stress, metabo
Age-related Cognitive Decline
DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving DonepezilN/A
COMPLETED·NCT02711683 · First Affiliated Hospital Xi'an Jiaotong University
92 enrolled · 2016-03 · → 2019-12
Alzheimer's disease (AD) is the commonest cause of dementia. There is no effective treatment to cure the disease. Cholinesterase inhibitors, such as donepezil, are widely recommended to patients with
Alzheimer's Disease
DL-3-n-butylphthalide Donepezil
A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)PHASE3
COMPLETED·NCT03391882 · Sumitomo Pharma America, Inc.
113 enrolled · 2018-12-19 · → 2021-08-11
A study of an investigational drug to see how it affects the people with Parkinson's Disease complicated by motor fluctuations ("OFF" Episodes) compared to an approved drug used to treat people with P
Motor OFF Episodes Associated With Parkinson's Disease
APL-130277 subcutaneous apomorphine
Protective Anesthesiological Management Procedure Imposes Control on Respiratory ComlicationsNA
UNKNOWN·NCT06282003 · Masa Kontic
53 enrolled · 2023-10-10 · → 2024-06-30
Anesthetic effects, surgery, and invasive mechanical intubation can impair respiratory function during general anesthesia. The risk factors for postoperative pulmonary complications (PPCs) include the
Well-Being, Psychological
The procedure of protective lung ventilation
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHDPHASE3
COMPLETED·NCT02168127 · Rhodes Pharmaceuticals, L.P.
360 enrolled · 2014-05 · → 2015-05
The purpose of this six month, open-label study is to evaluate the long-term safety and efficacy of PRC-063 in adults and adolescents with ADHD.
ADHD
Drug: PRC-063 PRC-063
5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant TumorN/A
COMPLETED·NCT02632370 · Constantinos Hadjipanayis
69 enrolled · 2016-05 · → 2018-12-31
In support of the US marketing application for 5-ALA, this single arm trial is being conducted to establish the efficacy and safety of Gliolan® (5-ALA) in patients with newly diagnosed or recurrent ma
Malignant Gliomas
Gliolan® Fluorescence-Guided Surgery
Magnetic Resonance Imaging of Brain Development in AutismN/A
UNKNOWN·NCT00449566 · UMC Utrecht
300 enrolled · 2006-01
The purpose of this study is to investigate brain development in autism by longitudinally assessing children with autism, as well as typically developing controls, using advanced MR techniques. We wil
Autism

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for GRIN2B →

No DepMap CRISPR Chronos data found for GRIN2B.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline
2.0 years

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
0

💾 Resource Usage

LLM Tokens
18,988
$0.1139
Total Cost
$0.1139
View on SciDEX ↗